Package 61703-343-18

{"route": ["INTRAVENOUS"], "spl_id": "8658f2e1-ad36-4ce0-af12-80814bd8bf5c", "openfda": {"unii": ["U6USW86RD0"], "rxcui": ["197989"], "spl_set_id": ["accf9569-4b57-4e83-a7db-4e890a75d1ba"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "61703-343-18", "marketing_start_date": "20060411"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65)  / 12.5 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "61703-343-65", "marketing_start_date": "20060411"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-66)  / 15 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "61703-343-66", "marketing_start_date": "20060411"}], "brand_name": "Mitoxantrone", "product_id": "61703-343_8658f2e1-ad36-4ce0-af12-80814bd8bf5c", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "61703-343", "generic_name": "Mitoxantrone", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mitoxantrone", "active_ingredients": [{"name": "MITOXANTRONE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA076871", "marketing_category": "ANDA", "marketing_start_date": "20060411", "listing_expiration_date": "20261231"}